POMMADE MIDY 1 G / 100 G
BENZOCAINE : 1 G / 100 G HAMAMELIS VIRGINIANA : 500 MG / 100 G AESCULUS HIPPOCASTANUM : 2.5 G / 100 G AMYLOCAINE HYDROCHLORIDE : 1 G / 100 G · DIN 00292591 · WELCKER-LYSTER LTD., DIVISION OF TECHNILAB INC.
Health Canada status: CANCELLED POST MARKET
What is POMMADE MIDY?
POMMADE MIDY 1 G / 100 G contains BENZOCAINE : 1 G / 100 G HAMAMELIS VIRGINIANA : 500 MG / 100 G AESCULUS HIPPOCASTANUM : 2.5 G / 100 G AMYLOCAINE HYDROCHLORIDE : 1 G / 100 G. It is listed in the Health Canada Drug Product Database under DIN 00292591, held by WELCKER-LYSTER LTD., DIVISION OF TECHNILAB INC., supplied as OINTMENT for RECTAL administration. Health Canada currently lists it as cancelled post market, status dated 17-Sep-1999. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00292591 |
|---|---|
| Brand name | POMMADE MIDY |
| Generic / active ingredient | BENZOCAINE : 1 G / 100 G HAMAMELIS VIRGINIANA : 500 MG / 100 G AESCULUS HIPPOCASTANUM : 2.5 G / 100 G AMYLOCAINE HYDROCHLORIDE : 1 G / 100 G |
| Manufacturer | WELCKER-LYSTER LTD., DIVISION OF TECHNILAB INC. |
| Strength | 1 G / 100 G |
| Dosage form | OINTMENT |
| Route of administration | RECTAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | C05AD20 ANESTHETICS, COMBINATIONS |
| AHFS class | 84:08.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 17-Sep-1999 |
| Original market date | 1948-12-31 00:00:00 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.